Skip to main content
Professional Technical IVT

Leukoencephalopathy

Pronunciation: LOO-koh-en-SEF-ah-lop-ah-thee

Damage to the brain's white matter, often appearing as treatment-related complications in neuro-oncology patients.

Full Definition

Leukoencephalopathy refers to damage or disease affecting the white matter of the brain, characterized by demyelination and tissue changes visible on magnetic resonance imaging. In neuro-oncology, this condition commonly develops as a late effect of radiation therapy or chemotherapy treatment. Progressive multifocal leukoencephalopathy (PML) represents a specific infectious variant that may occur in immunocompromised cancer patients. The condition manifests as confluent white matter abnormalities on FLAIR and T2-weighted images and can significantly impact cognitive function and quality of life. Editors should recognize this as both a treatment complication and differential diagnosis in brain tumor patients.

Usage

Usage note: May be treatment-related or infectious; requires differentiation from tumor progression.

In Context

  • "Follow-up MRI revealed progressive leukoencephalopathy consistent with radiation-induced white matter changes." — Neuroimaging report
  • "The patient developed cognitive decline secondary to treatment-related leukoencephalopathy." — Neurology consultation

Also known as

white matter disease

Don't confuse with

tumor recurrence radiation necrosis

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON